Eiji Umemoto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Eiji Umemoto has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
Katsuhiro Nakanishi
Laboratory of Microbiology and Immunology, School of Pharmaceutical Sciences, University of Shizuoka
3 shared publicationsKazuki Maeshima
Laboratory of Microbiology and Immunology, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan
2 shared publicationsKiyoshi Takeda
Department of Microbiology and Immunology, Graduate School of Medicine, Osaka University, Osaka, Japan
2 shared publications- Masayuki Miyasaka
Immunology Frontier Research Center, Osaka University, Suita, Japan
2 shared publications Michio Tomura
Laboratory of Immunology, Faculty of Pharmacy, Osaka Ohtani University, Osaka, Japan
2 shared publicationsYo Okamura
Laboratory of Microbiology and Immunology, School of Pharmaceutical Sciences, University of Shizuoka
2 shared publications
Latest Publications
- Open Access
- 6 November 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 2000061
From gut entry to hepatic defense: spatial and temporal coordination of host immunity to Listeria infection
Listeria monocytogenes , a facultative intracellular bacterium that causes listeriosis, infects the host primarily through contaminated food. After translocating across the intestinal epithelium, L. monocytogenes multiplies and spreads to secondary organs, such as the liver and spleen. While L. monocytogenes employs multiple mechanisms to invade host tissues, survive within host cells, and modulate immune responses, the host mounts coordinated innate and adaptive immune responses to restrict bacterial dissemination and establish protective immunity. In Peyer’s patches (PPs), a subset of mononuclear phagocytes termed LysoDCs captures bacteria translocated through M cells and contributes to the induction of Listeria -specific T-cell responses. Adaptive immune responses in PPs and mesenteric lymph nodes (MLNs), particularly CTL and Th1 responses, contribute to the establishment of long-term protection. Inflammatory monocytes are recruited to infected tissues, including the intestine and liver, where they contribute to bacterial control through antimicrobial effector mechanisms, including the production of inducible nitric oxide synthase (iNOS) and tumor necrosis factor-alpha (TNF-α). In this review, we summarize the mechanisms underlying intestinal invasion by L. monocytogenes , bacterial strategies that interfere with host defense, and the immune responses that control infection from the intestinal mucosa to systemic organs, particularly the liver. We focus on immune responses in PPs and MLNs and the mechanisms regulating inflammatory monocyte trafficking and function during L. monocytogenes infection. We also discuss recent findings showing that the pyruvate–GPR31 axis promotes dendrite extension by LysoDCs into M-cell pockets and facilitates bacterial sampling, whereas GPR35 promotes recruitment of inflammatory monocytes from the circulation into infected tissues. Together, these findings highlight immune-cell positioning and trafficking as important components of the spatial and temporal coordination of host defense against L. monocytogenes .
- 6 November 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 2000061
Open AccessFrom gut entry to hepatic defense: spatial and temporal coordination of host immunity to Listeria infection
Listeria monocytogenes , a facultative intracellular bacterium that causes listeriosis, infects the host primarily through contaminated food. After translocating across the intestinal epithelium, L. monocytogenes multiplies and spreads to secondary organs, such as the liver and spleen. While L. monocytogenes employs multiple mechanisms to invade host tissues, survive within host cells, and modulate immune responses, the host mounts coordinated innate and adaptive immune responses to restrict bacterial dissemination and establish protective immunity. In Peyer’s patches (PPs), a subset of mononuclear phagocytes termed LysoDCs captures bacteria translocated through M cells and contributes to the induction of Listeria -specific T-cell responses. Adaptive immune responses in PPs and mesenteric lymph nodes (MLNs), particularly CTL and Th1 responses, contribute to the establishment of long-term protection. Inflammatory monocytes are recruited to infected tissues, including the intestine and liver, where they contribute to bacterial control through antimicrobial effector mechanisms, including the production of inducible nitric oxide synthase (iNOS) and tumor necrosis factor-alpha (TNF-α). In this review, we summarize the mechanisms underlying intestinal invasion by L. monocytogenes , bacterial strategies that interfere with host defense, and the immune responses that control infection from the intestinal mucosa to systemic organs, particularly the liver. We focus on immune responses in PPs and MLNs and the mechanisms regulating inflammatory monocyte trafficking and function during L. monocytogenes infection. We also discuss recent findings showing that the pyruvate–GPR31 axis promotes dendrite extension by LysoDCs into M-cell pockets and facilitates bacterial sampling, whereas GPR35 promotes recruitment of inflammatory monocytes from the circulation into infected tissues. Together, these findings highlight immune-cell positioning and trafficking as important components of the spatial and temporal coordination of host defense against L. monocytogenes .
- Open Access
- 2 December 2025
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 82 (1) , 433
GPR35 mediates monocyte recruitment to the sites of Listeria monocytogenes infection
Recruitment of Ly6Chi monocytes to infection sites critically contributes to the clearance of microbial pathogens. However, the mechanism regulating their migration from the peripheral blood to the infected sites remains unresolved. In this study, we demonstrate that G protein-coupled receptor GPR35 is required for the entry of circulating Ly6Chi monocytes into the sites of Listeria monocytogenes infection. Gpr35−/− mice showed a decrease in Ly6Chi monocyte recruitment to the cecum and colon after oral administration of L. monocytogenes. They also exhibited a reduction in Ly6Chi monocytes in the liver and spleen upon intravenous infection. Mechanistically, GPR35 signaling enhanced Mac-1- and LFA-1-dependent Ly6Chi monocyte adhesion to ICAM-1, and GPR35-dependent integrin activation was important for their in vivo recruitment to infected sites. A potential GPR35-reactive metabolite, lysophosphatidic acid, accumulated around the bacterial foci near to the blood vessels. In addition, the GPR35 signal induced TNF-α production by Ly6Chi Sca-1+ monocytes and restricted the bacterial burden of L. monocytogenes. Collectively, GPR35-mediated signaling provides the molecular cue for elimination of L. monocytogenes by recruiting circulating Ly6Chi monocytes to the infected sites where they produce TNF-α.
- 2 December 2025
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 82 (1) , 433
Open AccessGPR35 mediates monocyte recruitment to the sites of Listeria monocytogenes infection
Recruitment of Ly6Chi monocytes to infection sites critically contributes to the clearance of microbial pathogens. However, the mechanism regulating their migration from the peripheral blood to the infected sites remains unresolved. In this study, we demonstrate that G protein-coupled receptor GPR35 is required for the entry of circulating Ly6Chi monocytes into the sites of Listeria monocytogenes infection. Gpr35−/− mice showed a decrease in Ly6Chi monocyte recruitment to the cecum and colon after oral administration of L. monocytogenes. They also exhibited a reduction in Ly6Chi monocytes in the liver and spleen upon intravenous infection. Mechanistically, GPR35 signaling enhanced Mac-1- and LFA-1-dependent Ly6Chi monocyte adhesion to ICAM-1, and GPR35-dependent integrin activation was important for their in vivo recruitment to infected sites. A potential GPR35-reactive metabolite, lysophosphatidic acid, accumulated around the bacterial foci near to the blood vessels. In addition, the GPR35 signal induced TNF-α production by Ly6Chi Sca-1+ monocytes and restricted the bacterial burden of L. monocytogenes. Collectively, GPR35-mediated signaling provides the molecular cue for elimination of L. monocytogenes by recruiting circulating Ly6Chi monocytes to the infected sites where they produce TNF-α.
- Open Access
- 27 September 2025
- Published by Elsevier in JID Innovations
- Vol. 6 (1) , 100420
Squaric Acid Dibutylester Promotes Innate Immune-Driven Hair Growth with CD206+ Macrophage Accumulation in the Dermis
- 27 September 2025
- Published by Elsevier in JID Innovations
- Vol. 6 (1) , 100420
Open AccessSquaric Acid Dibutylester Promotes Innate Immune-Driven Hair Growth with CD206+ Macrophage Accumulation in the Dermis
- Open Access
- 31 July 2025
- Published by Taylor & Francis in Gut Microbes
- Vol. 17 (1) , 2536089
Pyruvate–GPR31 axis induces LysoDC dendrite protrusion to M-cell pockets for effective immune responses
Peyer's patches (PPs) are sites of antigen entry and immunoinduction in the small intestine. In PPs, pathogens are transferred through microfold (M) cells; however, the mechanisms of antigen capture by mononuclear phagocytes beneath M cells remain unclear. Here, we demonstrate that bacterial metabolite pyruvate acted on lysozyme-expressing dendritic cells (LysoDCs), a monocyte-derived phagocyte subset, and induced protrusion of dendrites particularly with "balloon" shapes into basolateral M-cell pockets via its receptor, G-protein coupled receptor 31 (GPR31). Pyruvate administration in wild-type but not Gpr31b-deficient mice increased LysoDC uptake of orally infected Listeria monocytogenes. GPR31 signaling boosted antigen processing and altered gene expression. It also increased LysoDC migration to the interfollicular region, thereby promoting production of pathogen-specific Th1 cells as well as cytotoxic T cells, and effector T cell migration to the lamina propria. Furthermore, oral pyruvate administration conferred high resistance to a virulent L. monocytogenes strain in a GPR31-dependent manner. Collectively, the pyruvate - GPR31 axis plays critical roles in orchestrating intestinal protective immunity.
- 31 July 2025
- Published by Taylor & Francis in Gut Microbes
- Vol. 17 (1) , 2536089
Open AccessPyruvate–GPR31 axis induces LysoDC dendrite protrusion to M-cell pockets for effective immune responses
Peyer's patches (PPs) are sites of antigen entry and immunoinduction in the small intestine. In PPs, pathogens are transferred through microfold (M) cells; however, the mechanisms of antigen capture by mononuclear phagocytes beneath M cells remain unclear. Here, we demonstrate that bacterial metabolite pyruvate acted on lysozyme-expressing dendritic cells (LysoDCs), a monocyte-derived phagocyte subset, and induced protrusion of dendrites particularly with "balloon" shapes into basolateral M-cell pockets via its receptor, G-protein coupled receptor 31 (GPR31). Pyruvate administration in wild-type but not Gpr31b-deficient mice increased LysoDC uptake of orally infected Listeria monocytogenes. GPR31 signaling boosted antigen processing and altered gene expression. It also increased LysoDC migration to the interfollicular region, thereby promoting production of pathogen-specific Th1 cells as well as cytotoxic T cells, and effector T cell migration to the lamina propria. Furthermore, oral pyruvate administration conferred high resistance to a virulent L. monocytogenes strain in a GPR31-dependent manner. Collectively, the pyruvate - GPR31 axis plays critical roles in orchestrating intestinal protective immunity.
- Open Access
- 2 July 2025
- Published by Elsevier in Mucosal Immunology
- Vol. 18 (5) , 1113-1123
Fibroblast-derived CSF1 maintains colonization of gut mucosal macrophage to resist bacterial infection
- 2 July 2025
- Published by Elsevier in Mucosal Immunology
- Vol. 18 (5) , 1113-1123
Open AccessFibroblast-derived CSF1 maintains colonization of gut mucosal macrophage to resist bacterial infection
- Open Access
- 1 April 2019
- Published by Wiley in The FASEB Journal
- Vol. 33 (S1) , 523.2
High‐endothelial cell‐derived S1P regulates dendritic cell localization and vascular integrity in the lymph node
While the sphingosine‐1‐phosphate (S1P)/sphingosine‐1‐phosphate receptor‐1 (S1PR1) axis is critically important for lymphocyte egress from lymphoid organs, S1PR1 activation also occurs in vascular endothelial cells (ECs), including those of the high‐endothelial venules (HEVs) that mediate lymphocyte immigration into lymph nodes (LNs). To understand the functional significance of the S1P/S1PR1‐Gi axis in HEVs, we generated Lyve1‐Spns2 Δ/Δ conditional knockout mice for the S1P‐transporter Spinster‐homologue‐2 (Spns2), as HEVs express Lyve1 during development. In these mice, HEVs appeared apoptotic and were severely impaired in function, morphology and size; leading to markedly hypotrophic peripheral LNs. Within these LN, dendritic cells (DCs) were unable to interact with HEVs, which was also observed in VEcad‐CRE ERT2 ‐S1PR1 Δ/Δ mice and wildtype mice treated with S1PR1‐antagonists. Wildtype HEVs treated with S1PR1‐antagonists in vitro , as well as Spns2‐deficient HEVs in vivo , show severely reduced release of the DC‐chemoattractant CCL21. Together, our results reveal that EC‐derived S1P warrants HEV‐integrity through autocrine control of S1PR1‐G i signaling, and facilitates concomitant HEV‐DC interactions. Support or Funding Information This work was supported by Grants‐in‐Aid for Scientific Research (A) from the Japan Society for the Promotion of Science (JSPS; JP25253070 and JP16H02619 to M.I.); Grants‐in‐Aid for Young Scientists (B) from the JSPS (JP26860329 to S.S.); grants from the Takeda Science Foundation (to M.I.); from the Uehara Memorial Foundation (to M.I.); from the Kanae Foundation for the Promotion of Medical Sciences (to M.I.); and from the Kishimoto Foundation (to S.S.). This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .
- 1 April 2019
- Published by Wiley in The FASEB Journal
- Vol. 33 (S1) , 523.2
Open AccessHigh‐endothelial cell‐derived S1P regulates dendritic cell localization and vascular integrity in the lymph node
While the sphingosine‐1‐phosphate (S1P)/sphingosine‐1‐phosphate receptor‐1 (S1PR1) axis is critically important for lymphocyte egress from lymphoid organs, S1PR1 activation also occurs in vascular endothelial cells (ECs), including those of the high‐endothelial venules (HEVs) that mediate lymphocyte immigration into lymph nodes (LNs). To understand the functional significance of the S1P/S1PR1‐Gi axis in HEVs, we generated Lyve1‐Spns2 Δ/Δ conditional knockout mice for the S1P‐transporter Spinster‐homologue‐2 (Spns2), as HEVs express Lyve1 during development. In these mice, HEVs appeared apoptotic and were severely impaired in function, morphology and size; leading to markedly hypotrophic peripheral LNs. Within these LN, dendritic cells (DCs) were unable to interact with HEVs, which was also observed in VEcad‐CRE ERT2 ‐S1PR1 Δ/Δ mice and wildtype mice treated with S1PR1‐antagonists. Wildtype HEVs treated with S1PR1‐antagonists in vitro , as well as Spns2‐deficient HEVs in vivo , show severely reduced release of the DC‐chemoattractant CCL21. Together, our results reveal that EC‐derived S1P warrants HEV‐integrity through autocrine control of S1PR1‐G i signaling, and facilitates concomitant HEV‐DC interactions. Support or Funding Information This work was supported by Grants‐in‐Aid for Scientific Research (A) from the Japan Society for the Promotion of Science (JSPS; JP25253070 and JP16H02619 to M.I.); Grants‐in‐Aid for Young Scientists (B) from the JSPS (JP26860329 to S.S.); grants from the Takeda Science Foundation (to M.I.); from the Uehara Memorial Foundation (to M.I.); from the Kanae Foundation for the Promotion of Medical Sciences (to M.I.); and from the Kishimoto Foundation (to S.S.). This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .
- Open Access
- 12 January 2007
- Published by Wiley in FEBS Letters
- Vol. 581 (3) , 427-432
Aspirin prevents adhesion of T lymphoblasts to vascular smooth muscle cells
In the development of atherosclerosis, inflammatory cells adhere to and migrate into the vascular walls by interacting with vascular smooth muscle cells. To investigate the mechanism of aspirin's anti‐atherogenic activity, we examined whether aspirin inhibits the adhesion of lymphocytes to human aortic smooth muscle cells (AoSMC). Aspirin inhibited T‐cell adhesion to AoSMC activated by interleukin 1β (IL‐1β) in a dose‐dependent manner. Antibodies to the adhesion molecules ICAM‐1 or VCAM‐1, but not to E‐selectin, prevented T‐cell adhesion. ICAM‐1 and VCAM‐1 expression stimulated by IL‐1β was reduced by the treatment with aspirin, whereas the expression of E‐selectin was unaffected. Nuclear factor κB (NF‐κB) activity was enhanced by IL‐1β and reduced by aspirin, indicating that decreased ICAM‐1 and VCAM‐1 expression was due to reduced NF‐κB activity.Thus, aspirin inhibits the adhesion of Jurkat T cells to IL‐1β‐activated AoSMC by reducing NF‐κB activity and decreasing expression of ICAM‐1 and VCAM‐1, and may prevent the development of atherosclerosis.
- 12 January 2007
- Published by Wiley in FEBS Letters
- Vol. 581 (3) , 427-432
Open AccessAspirin prevents adhesion of T lymphoblasts to vascular smooth muscle cells
In the development of atherosclerosis, inflammatory cells adhere to and migrate into the vascular walls by interacting with vascular smooth muscle cells. To investigate the mechanism of aspirin's anti‐atherogenic activity, we examined whether aspirin inhibits the adhesion of lymphocytes to human aortic smooth muscle cells (AoSMC). Aspirin inhibited T‐cell adhesion to AoSMC activated by interleukin 1β (IL‐1β) in a dose‐dependent manner. Antibodies to the adhesion molecules ICAM‐1 or VCAM‐1, but not to E‐selectin, prevented T‐cell adhesion. ICAM‐1 and VCAM‐1 expression stimulated by IL‐1β was reduced by the treatment with aspirin, whereas the expression of E‐selectin was unaffected. Nuclear factor κB (NF‐κB) activity was enhanced by IL‐1β and reduced by aspirin, indicating that decreased ICAM‐1 and VCAM‐1 expression was due to reduced NF‐κB activity.Thus, aspirin inhibits the adhesion of Jurkat T cells to IL‐1β‐activated AoSMC by reducing NF‐κB activity and decreasing expression of ICAM‐1 and VCAM‐1, and may prevent the development of atherosclerosis.